Planning deficit in children with neurofibromatosis type 1: A neurocognitive trait independent from attention-deficit hyperactivity disorder (ADHD)?

Journal of Child Neurology

Volumn 29, Issue 10, 2014, Pages 1320-1326

  Galasso, Cinzia ^a   Lo Castro, Adriana ^a   Di Carlo, Loredana ^a   Pitzianti, Maria Bernarda ^a   D'Agati, Elisa ^a   Curatolo, Paolo ^a   Pasini, Auguslto ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

attention deficit hyperactivity disorder (ADHD); executive functions; neurofibromatosis type 1; planning; Tower of London

Indexed keywords

ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; COGNITIVE DEFECT; CONNERS SCALE; CONTROLLED STUDY; HUMAN; NEUROFIBROMATOSIS; PLANNING DEFICIT; PROBLEM SOLVING DEFICIT; RATING SCALE; SCHOOL CHILD; TOWER OF LONDON SCALE; COMPARATIVE STUDY; EXECUTIVE FUNCTION; FEMALE; MALE; NEUROFIBROMATOSIS TYPE 1; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; NEUROFIBROMATOSIS 1; NEUROPSYCHOLOGICAL TESTS;

EID: 84907602229     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073813517001     Document Type: Article

References (28)

1. Friedman JM Gene Reviews. Pagon RA Bird TD Dolan CR Stephens K Adam MP, ed. Seattle, WA: University of Washington ; 2012 :
2. Goh WH, Khong PL, Leung CS, Wong VC. T2 weighted hyperintensities (UBO) in children with NF1: their impact on cognitive function. J Child Neurol. 2004 ; 198: 853-858
3. Rosenbaum T, Engelbrecht V, Krölls W, et al. MRI abnormalities in neurofibromatosis type 1 (NF1): a study of men and mice. Brain Dev. 1999 ; 21: 268-273
4. Chabernaud C, Sirinelli D, Barbier C, et al. Thalamo-striatal T2-weighted hyperintensities (unidentified bright objects) correlate with cognitive impairments in neurofibromatosis type 1 during childhood. Dev Neuropsychol. 2009 ; 34: 736-748
5. Payne JM, Arnold SS, Pride NA, North KN. Does attention-deficit-hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1?. Dev Med Child Neurol. 2012 ; 54: 898-904
6. Payne JM, Barton B, Shores EA, North KN. Paired associate learning in children with neurofibromatosis type 1: implications for clinical trials. J Neurol. 2013 ; 260: 214-220
7. Hachon C, Iannuzzi S, Chaix Y. Behavioural and cognitive phenotypes in children with neurofibromatosis type 1 (NF1): the link with the neurobiological level. Brain Dev. 2011 ; 33: 52-61
8. Kayl AE, Moore BD. Behavioral phenotype of neurofibromatosis, type 1. Ment Retard Dev Disabil Res Rev. 2000 ; 6: 117-124
9. Levine TM, Materek A, Abel J, et al. Cognitive profile of neurofibromatosis type 1. Semin Pediatr Neurol. 2006 ; 13: 8-20
10. Payne JM, Hyman SL, Shores EA, North KN. Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior. Child Neuropsychol. 2011 ; 17: 313-329
11. Lo Castro A, D'Agati E. ADHD and genetic syndromes. Brain Dev. 2011 ; 33: 456-461
12. Roy A, Roulin JL, Charbonnier V, et al. Executive dysfunction in children with neurofibromatosis type 1: a study of action planning. J Int Neuropsychol Soc. 2010 ; 16: 1056-1063
13. Lehtonen A, Howie E, Trump D, Huson SM. Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence. Dev Med Child Neurol. 2013 ; 55: 111-125
14. Diagnostic and Statistical Manual of Mental Disorders (DSM), Text Revised. 4 th ed. Washington, DC: American Psychiatric Association; 2000. Washington, DC: American Psychiatric Association ; 2000 :
15. Ardila A, Rosselli M, Matute E, Guajardo S. The influence of the parents' educational level on the development of executive functions. Dev Neuropsychol. 2005 ; 28: 539-560
16. Wechsler D Wechsler Intelligence Scale for Children. 3 rd ed. San Antonio, TX: The Psychological Corporation; 1991. San Antonio, TX: The Psychological Corporation ; 1991 :
17. Conners CK Conners' Parents Rating Scales - Revised. Italian version by Nobile M, Alberti B, Zuddas A. Florence, Italy: Organizzazioni Speciali ; 2007 :
18. Solanto MV, Gilbert SN, Raj A, et al. Neurocognitive functioning in AD/HD, predominantly inattentive and combined subtypes. J Abnorm Child Psychol. 2007 ; 35: 729-744
19. Culbertson WC, Zillmer EA. Tower of London (DX): a standardized approach to assessing executive functioning in children. Arch Clin Neuropsychol. 1998 ; 13: 285-301
20. Carder HP, Handley SJ, Perfect TJ. Deconstructing the Tower of London: alternative moves and conflict resolution as predictors of task performance. Quart J Exp Psychol. 2004 ; 57A: 1459-1483
21. Bezeau S, Graves R. Statistical power and effect size of clinical neuropsychology research. J Clin Exp Neuropsychol. 2001 ; 23: 399-406
22. Stuss DT, Alexander MP. Executive functions and the frontal lobes: a conceptual view. Psychol Res. 2000 ; 63: 289-298
23. Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007 ; 164: 942-948
24. Pride NA, Payne JM, North KN. The impact of ADHD on the cognitive and academic functioning of children with NF1. Dev Neuropsychol. 2012 ; 37: 590-600
25. Mautner VF, Kluwe L, Thakker SD, Leark RA. Treatment of ADHD in neurofibromatosis type 1. Dev Med Child Neurol. 2002 ; 44: 164-170
26. Shilyansky C, Karlsgodt KH, Cummings DM. Neurofibromin regulates corticostriatal inhibitory networks during working memory performance. Proc Natl Acad Sci U S A. 2010 ; 107: 13141-13146
27. Ferraz-Filho JR, da Rocha AJ, Muniz MP. Unidentified bright objects in neurofibromatosis type 1: conventional MRI in the follow-up and correlation of microstructural lesions on diffusion tensor images. Eur J Paediatr Neurol. 2012 ; 16: 42-47
28. Ferraz-Filho JR, da Rocha AJ, Muniz MP, et al. Diffusion tensor MR imaging in neurofibromatosis type 1: expanding the knowledge of microstructural brain abnormalities. Pediatr Radiol. 2012 ; 42: 449-454